Acupuncture for Fatigue in Parkinson's Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01360229 |
Recruitment Status
:
Completed
First Posted
: May 25, 2011
Last Update Posted
: August 11, 2015
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Parkinsons Disease | Procedure: Acupuncture Other: Acupuncture to treat fatigue in Parkinson disease | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 88 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Acupuncture as a Symptomatic Treatment for Fatigue in Parkinson's Disease |
Study Start Date : | August 2010 |
Actual Primary Completion Date : | December 2014 |
Actual Study Completion Date : | May 2015 |

Arm | Intervention/treatment |
---|---|
Sham Comparator: Randomized Subjects receive a sham acupuncture.
Subjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.
|
Other: Acupuncture to treat fatigue in Parkinson disease
Subjects will be randomized in a 1:1 ratio to receive sham acupuncture.
|
Active Comparator: Randomized Subjects receive real acupuncture.
Subjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.
|
Procedure: Acupuncture
Subjects will be randomized in a 1:1 ratio to receive real acupuncture. Acupuncture is a procedure in which specific body areas are pierced with fine needles for therapeutic purposes
|
- Modified Fatigue Impact Scale (MFIS) between treatment groups [ Time Frame: 6 weeks ]The primary outcome measure will be the 6-week change in Modified Fatigue Impact Scale (MFIS) between treatment groups

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with PD
- Patients 40-99 years of age
- Patients who have significant fatigue
- Patients must be on a stable medication regimen for the treatment of PD
Exclusion Criteria:
- Patients who have had previous acupuncture within the past six months
- Patients who have had deep brain stimulation (DBS)
- Patients with dementia, depression, or sleep disorder
- Patients who are currently taking medications known to affect fatigue, such as stimulants

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01360229
United States, Colorado | |
University of Colorado Denver | |
Aurora, Colorado, United States, 80045 |
Principal Investigator: | Benzi Kluger, MD | University of Colorado, Denver |
Additional Information:
Responsible Party: | University of Colorado, Denver |
ClinicalTrials.gov Identifier: | NCT01360229 History of Changes |
Other Study ID Numbers: |
10-0533 |
First Posted: | May 25, 2011 Key Record Dates |
Last Update Posted: | August 11, 2015 |
Last Verified: | August 2015 |
Keywords provided by University of Colorado, Denver:
Parkinsons Disease Fatigue |
Additional relevant MeSH terms:
Parkinson Disease Fatigue Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases Signs and Symptoms |